Suivre
Connie Sanchez
Connie Sanchez
Alkermes
Adresse e-mail validée de alkermes.com
Titre
Citée par
Citée par
Année
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
C Sánchez, J Hyttel
Cellular and molecular neurobiology 19, 467-489, 1999
5701999
Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data
C Sanchez, KE Asin, F Artigas
Pharmacology & therapeutics 145, 43-57, 2015
5422015
The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
J Hyttel, KP Bøgesø, J Perregaard, C Sanchez
Journal of Neural Transmission/General Section JNT 88, 157-160, 1992
4211992
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder
A Mørk, A Pehrson, LT Brennum, SM Nielsen, H Zhong, AB Lassen, ...
Journal of Pharmacology and Experimental Therapeutics 340 (3), 666-675, 2012
3542012
Escitalopram versus citalopram: the surprising role of the R-enantiomer
C Sánchez, KP Bøgesø, B Ebert, EH Reines, C Braestrup
Psychopharmacology 174, 163-176, 2004
3452004
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression: are they all alike?
C Sanchez, E Meier
Psychopharmacology 129, 197-205, 1997
3351997
Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and …
C Sanchez, PBF Bergqvist, LT Brennum, S Gupta, S Hogg, A Larsen, ...
Psychopharmacology 167, 353-362, 2003
3332003
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
C Sanchez, EH Reines, SA Montgomery
International clinical psychopharmacology 29 (4), 185-196, 2014
2952014
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
E Dale, B Bang-Andersen, C Sánchez
Biochemical pharmacology 95 (2), 81-97, 2015
2832015
Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain
M El Mansari, C Sánchez, G Chouvet, B Renaud, N Haddjeri
Neuropsychopharmacology 30 (7), 1269-1277, 2005
2272005
The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats
A Mørk, M Kreilgaard, C Sanchez
Neuropharmacology 45 (2), 167-173, 2003
2132003
Stress-induced vocalisation in adult animals. A valid model of anxiety?
C Sánchez
European Journal of Pharmacology 463 (1-3), 133-143, 2003
2132003
The S-enantiomer of R, S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter …
F Chen, MB Larsen, C Sánchez, O Wiborg
European Neuropsychopharmacology 15 (2), 193-198, 2005
2122005
Escitalopram (S‐enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model
SA Montgomery, H Loft, C Sánchez, EH Reines, M Papp
Pharmacology & toxicology 88 (5), 282-286, 2001
2072001
The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice
C Sánchez, J Arnt, J Hyttel, EK Moltzen
Psychopharmacology 110, 53-59, 1993
2011993
Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
AL Pehrson, C Sanchez
CNS spectrums 19 (2), 121-133, 2014
1892014
Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice
SL Hansen, BB Sperling, C Sánchez
Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (1), 105-113, 2004
1862004
Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—a rat microdialysis and electrophysiology study
AL Pehrson, T Cremers, C Bétry, MGC van der Hart, L Jørgensen, ...
European Neuropsychopharmacology 23 (2), 133-145, 2013
1792013
Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro
J Arnt, J Hyttel, C Sánchez
European journal of pharmacology 213 (2), 259-267, 1992
1781992
Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro
J Arnt, J Hyttel, C Sánchez
European journal of pharmacology 213 (2), 259-267, 1992
1781992
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20